Evidence map›Paper›PMID 41422087›Full record

ArticleJournal of pharmaceutical health care and sciences2025

Evaluation of the pSMILE (Palliative care-Situational Motivating Interactive Learning and Education) educational program based on web-based and face-to-face workshops for palliative care pharmacists.

Megumi Kabeya, Mayako Uchida, Masahiko Amagawa, Makio Imamura, Yoko Kasahara, Yasunori Miyamoto, Takuya Yano, Takayuki Nakagawa

Abstract read
In one paragraph

Article in Journal of pharmaceutical health care and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Megumi KabeyaDepartment of Pharmacy, Nagoya Memorial Hospital, 4-305 Hirabari, Tempaku-Ku, Nagoya, Aichi, 468-8520, Japan. m-kabeya@hospy.or.jp.
Mayako UchidaDepartment of Clinical Pharmacology and Therapeutics, Kyushu University Hospital, 3-1-1, Maidashi, Higashi-Ku, Fukuoka, Fukuoka, 812-8582, Japan.
Masahiko AmagawaDepartment of Pharmacy and Cooperation, Palliative Care Clinic Ippo, 790 Kyome-Machi, Takasaki, Gunma, 370-0011, Japan.
Makio ImamuraDepartment of Clinical Support, Kurashiki Medical Center, 250 Bakuro-Cho, Kurashiki, Okayama, 710-8522, Japan.
Yoko KasaharaDepartment of Pharmacy, Akimoto Clinic, Hiroshima, 3-34 Inari-Machi, Kaita-Cho, Aki-Gun, Hiroshima, 736-0067, Japan.
Yasunori MiyamotoDepartment of Pharmacy, Hamamatsu Medical Center, 328 Tomitsuka-Cho, Chuo-Ku, Hamamatsu, Shizuoka, 432-8580, Japan.
Takuya YanoDepartment of Pharmacy, Sumitomo Besshi Hospital, 3-1 Oji-Cho, Niihama, Ehime, 792-8543, Japan.
Takayuki NakagawaDepartment of Clinical Pharmacology and Pharmacotherapy, Wakayama Medical University, 25 Shichibancho, Wakayama, 640-8156, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2021, the Education and Training Committee of the Japanese Society for Pharmaceutical Palliative Care and Sciences established an educational training program for pharmacists in palliative care, named Palliative care-Situational Motivating Interactive Learning and Education (pSMILE), based on web-based and face-to-face workshops. The program aims to enhance pharmacists' knowledge of palliative care and develop communication and cooperation skills.

methodsWe constructed a web-based pSMILE training program, which was later adapted for face-to-face workshops. This program consisted of two sessions, with the first half at a hospital and the second half at a clinic or community pharmacy. The participants could choose from three learning scenarios. A post-survey (within 1 week of the workshop) assessed usefulness, difficulty, length, and satisfaction. Participants also completed a web-based survey on behavioral changes related to daily palliative care following the workshop. Nine items on behavioral changes were assessed before and 1 month after the workshop, which was held from April 2021 to March 2024.

resultsTwelve pSMILE workshops were held during this period (10 web-based and two face-to-face). A total of 296 pharmacists participated, 152 (51.4%) of whom were Board Certified Pharmacist in Palliative Pharmacy, and 292 (98.6%) responded to the before/after workshop survey. Usefulness ratings were 4.39 for Session I and 4.20 for Session II. Satisfaction ratings were high (≥ 4.5), with no significant differences based on affiliation, training format, or certification. All confidence scores of nine daily palliative care behaviors (symptom assessment; multidisciplinary information sharing; proposing pharmacotherapy; polypharmacy intervention; palliative pharmacotherapy with awareness of pharmacokinetics; explanation of delirium; response in the discharge conference; information sharing between hospitals, clinics, and community pharmacies; and pharmacotherapy suggestions in view of the post-discharge) improved significantly post-workshop (p < 0.01), across both web-based and face-to-face workshops. Certified participants had higher confidence scores both before and after the workshop, and each group showed a significant improvement.

conclusionsThese results suggest that either web-based or face-to-face pSMILE workshops improve the quality of pharmacists' contribution in daily palliative care. This is the first report on the effectiveness of an academically approved web-based educational program for palliative care pharmacists, comparable to face-to-face workshops.

Indexed as

Behavioral changesJapanese Society for Pharmaceutical Palliative Care and SciencesPalliative carePharmacist educationpSMILEWeb-based workshop

Identifiers

PMID41422087
PMCPMC12720441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.